Anne B. O.
- Country
- Denmark
- Department
- Urologisk afdeling Afsnit Nord
Research Overview
- Evaluation of 64Cu-DOTA-AE105 PET Imaging for ISUP Grade Classification in Localized, Untreated Prostate Cancer Patients
- Open-Label Extension Study on Long-Term Safety of Enzalutamide in Prostate Cancer Patients from Previous Clinical Trials
- (21492 ARASTEP) A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer
Data & Insights
Has run more than one trial at 21 of 166 partner sites.
Specializations
Prostate Cancer Management
The investigator specializes in the treatment of biochemically recurrent prostate cancer and various stages of localized prostate cancer, with particular emphasis on innovative therapeutic approaches.
- Hormone Therapy Optimization
- Recurrence Prevention Strategies
- Advanced Treatment Combinations
A key focus lies in evaluating therapeutic interventions using androgen deprivation therapy (ADT) combinations for prostate cancer management.
Diagnostic Innovation
The investigator advances diagnostic capabilities through the application of novel imaging techniques for prostate cancer detection and monitoring.
- PET Imaging Applications
- Biomarker Assessment
- Disease Classification Methods
Expertise includes the evaluation of uPAR PET imaging methodologies for accurate disease characterization and staging.
Treatment Safety Evaluation
The investigator conducts comprehensive assessments of long-term treatment safety in prostate cancer therapies, particularly focusing on established and emerging therapeutic agents.
- Safety Profile Analysis
- Treatment Response Monitoring
- Clinical Benefit Assessment
Special attention is given to evaluating the sustained efficacy of targeted therapeutic approaches in prostate cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.